Trupanion (NASDAQ:TRUP) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.
Several other equities analysts have also commented on TRUP. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Thursday, January 10th. ValuEngine upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Wednesday, November 21st. Canaccord Genuity restated a “buy” rating and set a $43.00 price target on shares of Trupanion in a research report on Tuesday, November 13th. Finally, CL King upgraded shares of Trupanion from a “neutral” rating to a “buy” rating in a research report on Tuesday, October 2nd. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $43.67.
Trupanion stock opened at $25.75 on Tuesday. The stock has a market cap of $940.44 million, a PE ratio of -367.86 and a beta of 1.23. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.80 and a quick ratio of 1.80. Trupanion has a one year low of $22.38 and a one year high of $46.70.
In related news, CFO Tricia Plouf sold 1,300 shares of the stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $30.00, for a total value of $39,000.00. Following the completion of the transaction, the chief financial officer now owns 1,300 shares in the company, valued at approximately $39,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Darryl Rawlings sold 85,053 shares of the stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $23.61, for a total transaction of $2,008,101.33. Following the completion of the transaction, the insider now owns 1,555,997 shares of the company’s stock, valued at approximately $36,737,089.17. The disclosure for this sale can be found here. Insiders sold a total of 342,265 shares of company stock valued at $8,719,518 in the last quarter. 20.70% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in TRUP. SG Americas Securities LLC bought a new position in Trupanion in the 2nd quarter valued at about $100,000. Tower Research Capital LLC TRC bought a new position in Trupanion in the 3rd quarter valued at about $118,000. Jane Street Group LLC bought a new position in Trupanion in the 3rd quarter valued at about $231,000. New Jersey Better Educational Savings Trust grew its position in Trupanion by 42.9% in the 3rd quarter. New Jersey Better Educational Savings Trust now owns 10,000 shares of the financial services provider’s stock valued at $357,000 after buying an additional 3,000 shares in the last quarter. Finally, Atlantic Trust LLC grew its position in Trupanion by 53.5% in the 3rd quarter. Atlantic Trust LLC now owns 9,995 shares of the financial services provider’s stock valued at $357,000 after buying an additional 3,485 shares in the last quarter. Hedge funds and other institutional investors own 95.56% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: How is the LIBOR rate calculated?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.